Valor-qi program

Intervention

1 paper2 findings

  • 1 lab
  • Human trial1

Outcomes

2

Patients with LDL-C >100 mg/dL

downin humans1

1 study
  1. Valor-qi program decreases patients with LDL-C >100 mg/dL in humans (78% to 49%).

    “and the proportion with levels >100 mg/dL dropped to 49%”

    Human trialVeterans with ASCVD and baseline LDL-C >70 mg/dLAugust 2023 through May 2025n = 96

    Enhancing Lipid Management in Veterans: Integrating Whole Health Principles through the VALOR-QI Program and Veterans Health Administration

    AHA Scientific Sessions 2025 abstract3 Nov 2025

Patients with LDL-C <70 mg/dL

upin humans1

1 study
  1. Valor-qi program increases patients with LDL-C <70 mg/dL in humans.

    “By May 2025, 33% had reached the target of LDL-C <70 mg/dL”

    Human trialVeterans with ASCVD and baseline LDL-C >70 mg/dLAugust 2023 through May 2025n = 96

    Enhancing Lipid Management in Veterans: Integrating Whole Health Principles through the VALOR-QI Program and Veterans Health Administration

    AHA Scientific Sessions 2025 abstract3 Nov 2025

Latest

Nov 2025: 1Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months